Lactosan Oral Solution LACTULOSE 3.35 MG/5 ML
Country: Tanzania
Language: English
Source: Tanzania Medicinces & Medical Devices Authority
Summary of Product characteristics
(SPC)
28-02-2024
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Lactulose
Available from:
CORE PHARMA LIMITED, TANZANIA
ATC code:
Osmotically acting laxatives
INN (International Name):
Lactulose
Dosage:
LACTULOSE 3.35 MG/5 ML
Pharmaceutical form:
Oral Solution
Manufactured by:
Sanpras Healthcare Private Limited, INDIA
Product summary:
Physical description: Pale Brownish yellow coloured viscous solution; Local technical representative: CORE PHARMA LIMITED (1120)
Authorization status:
Registered/Compliant
Authorization date:
2023-06-01
Summary of Product characteristics
Effective date: 03/10/2022
TMDA/DMC/MRE/F/016
Rev #:02
THE UNITED REPUBLIC OF TANZANIA
MINISTRY OF HEALTH
TANZANIA MEDICINES AND MEDICAL DEVICES AUTHORITY
PUBLIC ASSESSMENT REPORT FOR LACTOSAN (LACTULOSE 3.35 MG/5 ML) ORAL
SOLUTION
Version number 1.0
21 August, 2023
TMDA Headquarters, Plot No. 56/1, Block E, Kisasa B Centre, Hombolo Road, P. O. Box
1253, Dodoma – Tanzania, Telephone: +255 (26) 2961989/2061990/+255 (22)
2450512/2450751/2452108, Email: info@tmda.og.tz, Website: www.tmda.go.tz
Toll free: 0800110084
Read the complete document
